Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
Filing tables
Filing exhibits
- 10-K Annual report
- 4.4 EX-4.4 Description of Securities Registered
- 10.33 EX-10.33 2ND Amendment to Office Lease Agreement, Dated As of December 30, 2020
- 10.34 EX-10.34 Third Amendment to Credit Agreement and Guaranty, March 25, 2022
- 10.35 EX-10.35
- 10.36 EX-10.36 A&r Intercompany Subordination Agreement, March 25, 2022
- 23.1 EX-23.1 Consent of Deloitte & Touche LLP
- 31.1 EX-31.1 Certification of the CEO Pursuant to Rule 13A-14(A) or 15D-14(A)
- 31.2 EX-31.2 Certification of the CFO Pursuant to Rule 13A-14(A) or 15D-14(A)
- 32.1 EX-32.1 Certification of CEO & CFO Pursuant to Section 906
- Download Excel data file
- View Excel data file
Associated PEARQ transcripts
PEARQ similar filings
Filing view
External links
Certification of Periodic Financial Report
Pursuant to 18 U.S.C. Section 1350
as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Each of the undersigned officers of Pear Therapeutics, Inc. (the “Company”) certifies, to his knowledge and solely for the purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Annual Report on Form 10-K of the Company for the year ended December 31, 2021 complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: March 28, 2022
/s/ Corey M. McCann | ||
Dr. Corey M. McCann | ||
Chief Executive Officer (Principal Executive Officer) |
Dated: March 28, 2022
/s/ Christopher D.T. Guiffre | ||
Christopher D.T. Guiffre | ||
Chief Financial Officer (Principal Financial Officer) |